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A B S T R A C T
Human papillomavirus (HPV) infection is the main cause of cervical cancer, the second most common cancer in
women worldwide. More than 200 types of HPV have been described, and within this range more than 40 types attack ep-
ithelium of genital tract. The types that were most commonly related to the development of cervical cancer are called
high-risk types (HR HPV). There are very few studies about HPV prevalence in Croatia and there is an absolute lack of
data for Split and Dalmatian County. Therefore, during a 6 month period, we routinely screened 570 women for HPV
DNA at the Educational Public Health Institute of Split and Dalmatian County. HR HPV was detected in cervical exfoli-
ated cells, by using Hybrid Capture 2 HPV DNA test. Out of the total number of tested women, 200 (35%) of them were
positive to HR HPV. Polymerase chain reaction (PCR) based assays were employed for HR HPV genotyping in positive
specimens. The following frequency was observed: HPV 16 in 10%, HPV 18 in 6.1%, HPV 31 in 2.6%, HPV 33 in 1.9%,
HPV 52 in 1.4%, HPV 59 in 0.7%, HPV 45 in 0.4% specimens, while 11.9% of tested specimens currently remained
untyped. It is necessary to expand this study to a larger number of women, in order to better evaluate genital HPV types
distribution among women in this region.
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Introduction
Cervical cancer is the second most common cancer in
women worldwide. Infection with Human papilloma-
virus (HPV) is the main cause of cervical cancer1. HPV is
the most common sexually transmitted viral disease and
one of the most frequent causal agents of sexually trans-
mitted diseases. Genital HPV infection is rarely reported
(there is no legal obligation). While its prevalence is as-
sumed to be higher than 20 million, the incidence of HPV
infection only in the United States ranges from one mil-
lion to 5.5 million per year2. The prevalence of HPV DNA
in cervical cancer cases is 99.7%3, while in cervical speci-
mens of women without cervical cancer ranges from 5%
to 20%4–6. More than 200 types of HPV are known, and
within this range more than 40 attack epithelium of gen-
ital tract. The types that are most commonly related to
the development of cervical cancer, so called oncogenic or
high-risk types (HR HPV), are: 16, 18, 31, 33, 34, 35, 39,
45, 51, 52, 56, 58, 59, 66, 68 and 702,7. The most common
HPV types in cervical cancer are: HPV type 16 (46% to
63%) and HPV type 18 (10% to 14%)7. There are very few
studies in Croatia about HPV prevalence related only to
cervical specimens of women with abnormal Papani-
colaou (Pap) smear, with the most common types: HPV
type 16 (11.4% to 20.2%) and HPV type 31 (5% to
17.8%)8–10. Concerning the absolute lack of data for Split
and Dalmatian County, we initiated a testing for HPV in
order to evaluate the prevalence in our region.
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Materials and Methods
In the Educational Public Health Institute of Split
and Dalmatian County, during the 6 months period in
2006, HPV screening tests were done in 570 women. The
age range of the study was 18 to 62 years (the average
age 40 years). The study population included all women
referred by their gynecologists for HPV DNA testing to
our laboratory, as a survey of general population (with
unknown cytological diagnosis). HR HPV was detected in
cervical exfoliated cells, by using Hybrid Capture 2 (HC2)
HPV DNA test (Digene Corporation, Gaithersburg, MD
USA). HC2 test was used in screening specimens for high-
risk types of HPV (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58,
59 and 68), which had been approved by Food and Drug Ad-
ministration (FDA, USA) for detection of HPV DNA in cer-
vical specimens for diagnostic purpose. This test cannot dif-
ferentiate individual types of HPV within the group2.
Only HR HPV positive specimens analyzed by HC2
test were sent for further genotyping. DNA was ex-
tracted from cervical cells, by using reagents Nucleo Spin
Tissue (Machery-Nagel, Düren, Germany). Genotypes
were distinguished by polymerase chain reaction (PCR)
based assays using primer sequences for HR HPV types:
16, 18, 31, 33, 45, 52, and 59 (Table 1). Positive and nega-
tive controls were included in each reaction. PCR reac-
tions were performed according to the manufacturer in-
struction on PCR system (Applied Biosystems, Foster
City, USA). PCR products were detected using agarose
gel electrophoresis (3% agarose gel). The specific primers
for amplification of the sequence containing E6 region of
HPV types: 16, 18 and 33 were used (TaKaRa, Bio. Inc.,
Japan)11–12. Amplification products yield DNA fragment
of 140 bp for HPV types: 16, 18 and 141 bp for HPV type
33. The presence of HPV types: 31, 45, 52 and 59 was de-
tected by using primers for amplification of the sequence
containing E7 region, described by Walboomers et al.3,
yielding a PCR product of 100 bp.
Results
During routine HPV testing in Split and Dalmatian
County, total of 570 women were tested, and 200 (35%) of
them were positive to HR HPV, when samples were as-
sessed by HC2 test. Only HR HPV positive specimens by
HC2 were further genotyped by PCR based assays. Our
analysis revealed the frequency of HPV 16 in 10%, HPV
18 in 6.1%, HPV 31 in 2.6%, HPV 33 in 1.9%, HPV 52 in
1.4%, HPV 59 in 0.7%, HPV 45 in 0.4% specimens (Table
2). Among HPV positive sample, HPV 16 was the more
abundantly found types in 28.5% cases, followed by HPV
18 (17.5%), 31 (7.5%), 33 (5.5%), 52 (4%), 59 (2%) and 45
(1%), while 68 (34%) specimens remained with unre-
solved genotype (Table 2). Multiple HPV infections were
found in two cases out of 200 (1%): HPV 16 and 33, and
HPV 18 and 31, respectively.
Discussion
Having in mind the absolute lack of data for Split and
Dalmatian County, we screened HPV prevalence in our
region. Our preliminary study included 570 women who
underwent routine screening as a survey of general pop-
ulation with either normal or abnormal Pap smears. Our
results showed that 35% of them were positive for HR
HPV. These positive samples detected by HC2 were fur-
ther genotyped by type-specific primer-directed PCR for
7 most common types of HR HPV (Table 1). In our study,
among HPV positive sample the most commonly found
HPV types were: HPV 16 in 28.5%, HPV 18 in 17.5%, and
HPV 31 in 7.5% specimens, while 68 (34%) specimens
currently remained undetermined (Table 2).
The prevalence of HR HPV in cervical specimens of
women without cervical cancer ranges from 5% to 20%
worldwide, while in healthy women with normal Pap
smears it is approximately 10%4–6. Among European
women with low grade lesions found in Pap smears, HPV
prevalence in exfoliated cells is 67.8%, with the most
common HPV types: HPV type 16 in 19.4% specimens
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HPV – Human Papillomavirus
TABLE 2
HIGH-RISK HPV FOUND IN THE CERVICAL SPECIMENS AMONG








16 57 10.0 28.5
18 35 6.1 17.5
31 15 2.6 7.5
33 11 1.9 5.5
52 8 1.4 4.0
59 4 0.7 2.0
45 2 0.4 1.0
others 68 11.9 34.0
HPV – Human Papillomavirus
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and HPV type 31 in 10.4% specimens. Prevalence of HPV
type 18 in Europe is 5.1%, but ranges from 0% to 31.4%,
compared by region13. Very few studies about HPV prev-
alence in Croatia were conducted. The studies presented
by Grce et al. analyzed only women with abnormal Pap
smears. According to these studies in Croatia, HPV prev-
alence in cervical specimens of women with abnormal
Pap smears ranges from 43% to 64%, with the most com-
mon types: HPV type 16 (11.4% to 20.2%) and HPV type
31 (5% to 17.8%)8–10. In our study, we had unexpectedly
high number of specimen without genotype (34%), in
comparison to studies by Grce et al. that reported from
23.7% to 49% of untyped HPV DNA positive samples9,10.
This result might be due to presence of other rare types
of HPV, insufficient quantity of DNA in the specimen or
due to differences between detection methods (HC2 and
PCR). The integrity of DNA from 68 specimens with un-
resolved HPV genotype was further tested for b-actin by
PCR, and 13 (19.1%) did not yield amplification product.
Our results of HR HPV genotyping are slightly differ-
ent from those found in other studies conducted in Cro-
atia due to several reasons. In previous studies regarding
HPV prevalence in Croatia, mainly women with abnor-
mal Pap smears were tested for the presence of HPV and
typed for a limited number of HPV types (HPV 6/11, 16,
18, 31 and 33)8–10. In our study, population included
women who were referred by their gynecologists for HPV
DNA testing to our laboratory (with unknown cytological
diagnosis). Furthermore, in this study HPV DNA posi-
tive samples by HC2 were further genotyped for more
HR HPV types (HPV 16, 18, 31, 33, 52, 59 and 45) than
those reported in previous studies. The frequency of
HPV types in the study of Grce et al. 20019 conducted on
1,874 cervical specimens collected in the region of Zagreb
and this study are similar for HPV types 16 (12 versus
10%) and 33 (2.7 versus 1.9%), but discordant for HPV
18 (2.4 versus 6.1%) and 31 (5.1 versus 2.6%). The reason
for these discrepancies could be (1) small number of ana-
lyzed sample in this study, (2) the choice of type-specific
primers for DNA amplification, and (3) different distri-
bution of HR HPV types in both Counties. Split and Dal-
matian County is an important tourist region of Croatia
with a high number of tourists passing through. It is also
a maritime centre with the port and significant number
of seamen that are carriers of HPV types gained from all
over the world and spread within this County. Due to
these reasons, it is important to continue this study on
larger number of specimens and to enlarge the spectrum
of genotyping of HR HPV in order to evaluate HPV geni-
tal types distribution among women in this region, espe-
cially in the context of HPV vaccine application.
Conclusion
The data obtained from our study indicate that HPV
16 and 18 are the most common HPV types found in the
cervical specimens among women of Split and Dalmatian
County as in most studies worldwide. However, low abun-
dant HR HPV types differ between regions in Croatia. In
our opinion, it is necessary to expand this study to a
larger number of women in order to obtain a better dis-
tribution of HR HPV types in Split and Dalmatian Co-
unty.
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RASPODJELA POJEDINIH TIPOVA HUMANOGA PAPILLOMA VIRUSA U UZORCIMA
OBRISKA VRATA MATERNICE @ENA SPLITSKO-DALMATINSKE @UPANIJE
S A @ E T A K
Infekcija uzrokovana human papillomavirusom (HPV) je glavni ~imbenik razvoja karcinoma vrata maternice, dru-
goga po u~estalosti me|u karcinomima u `ena u svijetu. Poznato je vi{e od 200 tipova HPV-a, od kojih vi{e od 40 tipova
napada epitel spolnoga sustava. Tipovi koji se naj~e{}e povezuju s razvojem karcinoma vrata maternice nazivaju se
visokorizi~ni tipovi (HR, engl. High Risk HPV). U Hrvatskoj je, do sada, napravljeno svega nekoliko studija o pre-
valenciji HPV-a, a ne postoje nikakvi podatci za Splitsko-dalmatinsku `upaniju. Zbog toga smo, u Nastavnom zavodu za
javno zdravstvo Splitsko-dalmatinske `upanije, napravili probir 570 `ena na HPV DNK, u razdoblju od 6 mjeseci. HR
HPV dokazan je u obriscima vrata maternice, metodom HC2 (Hybrid Capture 2, Digene). Od ukupnoga broja testiranih
`ena njih 200 (35%) je bilo pozitivno na visokorizi~ne tipove HPV-a. Daljnjom genotipizacijom HR HPV pozitivnih uzo-
raka, metodom lan~ane reakcije polimerazom (PCR, engl. Polymerase Chain Reaction), utvr|ena je u~estalost tipa 16 u
10% uzoraka, tipa 18 u 6,1%, tipa 31 u 2,6%, tipa 33 u 1,9%, tipa 52 u 1,4%, tipa 59 u 0,7%, tipa 45 u 0,4% uzoraka, dok
su 11,9% uzorka, za sada, ostala netipizirana. Smatramo da je neophodno pro{iriti studiju na ve}i broj ispitanica, te
nastaviti pra}enje pro{irenosti pojedinih tipova HPV-a u `ena ove regije.
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